Fremanezumab reduces migraine frequency in children and adolescents with episodic migraine
1. In this randomized controlled trial involving pediatric patients, fremanezumab led to greater reductions in the number of migraine days ...
1. In this randomized controlled trial involving pediatric patients, fremanezumab led to greater reductions in the number of migraine days ...
1. In this randomized controlled trial, Fremanezumab slightly decreased the amount of headache free days in those with episodic migraines ...
1. Patients with chronic migraine receiving fremanezumab had significantly fewer migraines and headaches than those receiving placebo after 12 weeks ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.